Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

Sharp acquires Berkshire Sterile Manufacturing

Firstsource Positioned as a ‘Leader’ and a ‘Star Performer’ in Everest Group Healthcare Payer Operations PEAK Matrix® Assessment 2023

About Firstsource Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL, BSE: 532809, Reuters: FISO.BO, Bloomberg: FSOL:IN), is a leading provider of transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, and other industries. The Company’s ‘Digital First, Digital Now’ approach helps organizations reinvent operations and reimagine business models, enabling them to deliver moments that matter and build competitive advantage. With an established presence in the US, the UK, Mexico, India, and the Philippines, Firstsource acts as a trusted growth partner for over 150 leading global brands, including several Fortune 500 and FTSE 100 companies. (www.firstsource.com)

InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023

InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023 - Recent research highlights the potential for model-informed precision dosing to improve patient safety, enhance clinical practice and reduce the cost of care

Phastar Net-Zero Target Approved by the Science Based Targets Initiative

Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar commits to achieving Net-Zero Standard by 2035

Almaden Genomics Adds Pre-Built Workflows to g.nome, Facilitating and Speeding Single-Cell RNA-seq Analysis

Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome™ platform, enabling understanding of cellular diversity and disease mechanisms on a much more granular level. By unlocking single-cell sequencing data through efficient and powerful analysis, g.nome can now help researchers better understand cellular heterogeneity and gene expression.

AVIA’s National Generative AI Collaborative Grows to Nearly Thirty Major Health Systems

BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa

Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.

BioIVT to Host a Webinar on Optimizing Liquid Biopsy Research

This webinar will discuss the importance of using standardized collection protocols and a diverse donor base to validate biomarkers and ensure their clinical utility.

Scitara and IDT present a composable IT architecture platform at Lab of The Future Europe 2023

Emendo Biotherapeutics Leaders Share Expert Insights on Cutting-Edge Gene Editing Advancements at October Industry Conferences

Executive Team Charts Path to Future Approval as the World Awaits a Historic Breakthrough in Precision Medicine

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

Takara Bio Inc. has announced that it has entered into a License Agreement with non-profit/charity organization, Telethon.

New hot start isothermal mixes boost sensitivity, specificity, and speed of DNA target detection

PCR Biosystems, a leading PCR reagent developer, has launched a new range of Bst polymerase reagents that offer greater sensitivity, speed, and specificity in all isothermal amplification applications.

Integrated DNA Technologies Reveals Launch of xGen™ Products for Ultima Genomics®

IDT is the first company to offer stocked products for Ultima Genomics platforms. Products include xGen™ NGS adapters, primers and universal blockers.

Phenomix Sciences Co-Founders Awarded First Patent for Using Precision Medicine and Phenotyping to Treat Obesity

Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced today the United States Patent and Trademark Office (USPTO) has issued the first patent related to its obesity phenotyping technology.

Creative Proteomics Introduces Mature Solutions for Membrane Protein Identification

Laverock Therapeutics raises £13.5M to develop unique gene silencing platform for programmable advanced therapies

Laverock Therapeutics, established in 2021 to commercialise the gene editing induced gene silencing (GEiGS®) platform for all human therapeutic applications, is pleased to announce that it has expanded its seed funding round to £13.5M.

Creative Proteomics Launches State-of-the-Art Peptide Sequencing Service to Advance Proteomics Research

Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment